Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 17 studies | 44% ± 16% | |
classical monocyte | 5 studies | 26% ± 9% | |
dendritic cell | 5 studies | 39% ± 18% | |
conventional dendritic cell | 4 studies | 34% ± 18% | |
epithelial cell | 4 studies | 17% ± 1% | |
non-classical monocyte | 3 studies | 22% ± 6% |
Insufficient scRNA-seq data for expression of RPS6KA4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2900.41 | 1445 / 1445 | 100% | 76.42 | 183 / 183 |
skin | 100% | 3529.02 | 1809 / 1809 | 100% | 62.16 | 472 / 472 |
uterus | 100% | 2470.01 | 170 / 170 | 100% | 63.78 | 459 / 459 |
brain | 100% | 3711.77 | 2635 / 2642 | 100% | 34.31 | 705 / 705 |
intestine | 100% | 2523.99 | 966 / 966 | 100% | 62.28 | 525 / 527 |
lung | 100% | 2819.35 | 578 / 578 | 100% | 50.73 | 1150 / 1155 |
thymus | 100% | 1799.56 | 652 / 653 | 100% | 31.88 | 603 / 605 |
ovary | 99% | 1326.51 | 179 / 180 | 100% | 37.15 | 430 / 430 |
prostate | 100% | 2237.61 | 245 / 245 | 99% | 39.32 | 499 / 502 |
kidney | 100% | 1943.10 | 89 / 89 | 99% | 30.39 | 893 / 901 |
stomach | 100% | 1998.71 | 358 / 359 | 99% | 62.34 | 284 / 286 |
bladder | 100% | 2647.67 | 21 / 21 | 98% | 62.22 | 495 / 504 |
breast | 100% | 2093.24 | 459 / 459 | 98% | 32.49 | 1092 / 1118 |
pancreas | 97% | 1106.39 | 318 / 328 | 99% | 59.02 | 177 / 178 |
adrenal gland | 100% | 1974.89 | 258 / 258 | 92% | 20.98 | 211 / 230 |
liver | 98% | 1012.05 | 221 / 226 | 94% | 20.27 | 381 / 406 |
adipose | 100% | 2325.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 89.56 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 53.60 | 29 / 29 |
spleen | 100% | 3960.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 84.39 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 45.04 | 1 / 1 |
blood vessel | 100% | 2343.03 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1393.77 | 852 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1429.66 | 794 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 1965.30 | 884 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032793 | Biological process | positive regulation of CREB transcription factor activity |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0006954 | Biological process | inflammatory response |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0043687 | Biological process | post-translational protein modification |
GO_0006338 | Biological process | chromatin remodeling |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0006468 | Biological process | protein phosphorylation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0044022 | Molecular function | histone H3S28 kinase activity |
GO_0004711 | Molecular function | ribosomal protein S6 kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0035175 | Molecular function | histone H3S10 kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RPS6KA4 |
Protein name | Ribosomal protein S6 kinase (EC 2.7.11.1) RPS6KA4 protein Ribosomal protein S6 kinase A4 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) |
Synonyms | MSK2 |
Description | FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. . |
Accessions | E9PKU3 A0PJF8 ENST00000528057.5 A0A0A6YYC0 E9PJN1 ENST00000334205.9 [O75676-1] ENST00000530504.1 O75676 ENST00000528355.5 |